15 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
to (a) protection of the environment, natural resources or public and worker health and safety, (b) exposure to, or the generation, management, manufacture
PREM14A
u632b0e0ae6mr24
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFA14A
EX-2.1
y3547byu1t0qd
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
3tiha7x79yft
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
S-3ASR
EX-1.2
d4nq2rgx3o9qx6sar30
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-1.1
lp2wpi2k
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-1.1
z77tgux
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
DEF 14A
hy9e 49mtma
7 Apr 14
Definitive proxy
12:00am
- Prev
- 1
- Next